A detailed history of Lvm Capital Management LTD transactions in Vaxart, Inc. stock. As of the latest transaction made, Lvm Capital Management LTD holds 12,500 shares of VXRT stock, worth $7,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,500
Previous 12,500 -0.0%
Holding current value
$7,750
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 07, 2023

BUY
$0.6 - $1.41 $7,500 - $17,625
12,500 New
12,500 $9,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $78.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Lvm Capital Management LTD Portfolio

Follow Lvm Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvm Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lvm Capital Management LTD with notifications on news.